Current advances in the diagnosis and treatment of renal artery stenosis

Reviews in Cardiovascular Medicine

Volumn 5, Issue 4, 2004, Pages 204-215

  Bokhari, Syed W ^a   Faxon, David P ^a  

^a Pritzker School of Medicine   (United States)

Author keywords

Hypertension; Renal artery disease; Renal insufficiency

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOPLASTY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ECHOGRAPHY; HEALTH CARE COST; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY FUNCTION; MAGNETIC RESONANCE ANGIOGRAPHY; MORTALITY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; REVASCULARIZATION; REVIEW; RISK FACTOR; STENT; SURGICAL TECHNIQUE; VASCULAR PATENCY;

HUMANS; PROGNOSIS; RENAL ARTERY OBSTRUCTION;

EID: 10944230402     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Rihal CS, Texter SC, Breen JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002;77:309-316.
2. Alhaddad IA, Blum S, Heller EN, et al. Renal artery stenosis in minority patients undergoing diagnostic cardiac catheterization: prevalence and risk factors. J Cardiovasc Pharmacol Ther. 2001;6:147-153.
3. Crowley JJ, Santos RM, Peter RH, et al. Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J. 1998;136:913-918.
4. Rundback J, Sacks D, Kent K, et al. Guidelines for reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol. 2002; 13:959-974.
5. White CJ. Screening renal artery angiography at the time of cardiac catheterization. Catheter Cardiovasc Interv. 2003;60:295-296.
6. Edwards MS, Hansen KJ, Craven TE, et al. Association between renovascular disease and prevalent cardiovascular disease in the elderly. A population-based study. Vasc Endovascular Surg. 2004;38:25-35.
7. Khosla S, Kunjummen B, Manda R, et al. Prevalence of renal artery stenosis requiring revascularization in patients initially referred for coronary angiography. Catheter Cardiovasc Interv. 2003;58:400-403.
8. Jean WJ, Al-Bittar I, Zwicke DL, et al. High incidence of renal artery stenosis in patients with coronary artery disease. Catheter Cardiovasc Diagn. 1994;32:8-10.
9. Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2;1608-1616.
10. Weber-Mzell D, Kotanko P, Schuacher M, et al. Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J. 2002;23:1684-1691.
11. Olin JW, Melia M, Young JR, et al. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88:46N-5IN.
12. Valentine RJ, Clagett GP, Miller GL, et al. The coronary risk of unsuspected renal artery stenosis. J Vasc Surg. 1993; 18:433-439.
13. Valentine RJ, Myers SI, Miller GL, et al. Detection of unsuspected renal artery stenosis in patients with abdominal aortic aneurysms; refined indications for preoperative aortography. Ann Vasc Surg. 1993;7:220-224.
14. Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal artery stenosis: where do we stand? A meta-analysis. Radiology. 2000;216:78-85.
15. Plouin PF, Chatellier G, Darne B, Raymond A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments versus Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823-829.
16. Kuroda S, Nishida N, Uzu T, et al. Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke. 2000;31:61-65.
17. Kennedy DJ, Colyer WR, Brewster PS, et al. Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis. 2003;42:926-935.
18. Textor SC. Managing renal arterial disease and hypertension. Curr Opin Cardiol. 2003; 18:260-267.
19. Ram CV. Renovascular hypertension. Curr Opin Nephrol Hypertens. 1997;6:575-579.
20. Ram CV, Clagett GP, Radford LR. Renovascular hypertension. Semin Nephrol. 1995;15:152-174.
21. Olin JW. Renal artery disease: diagnosis and management. Mt Sinai J Med. 2004;71:73-85.
22. Spitalewitz S, Reiser IW. Atherosclerotic renovascular disease. Am J Ther. 1996;3:21-28.
23. Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis. 2001; 37:1184-1190.
24. McCullough PA. Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med. 2002;3:71-76.
25. Bleyer AJ, Chen R, D'Agostino RB Jr, et al. Clinical correlates of hypertensive end-stage renal disease. Am J Kidney Dis. 1998;31:28-34.
26. Price DA, Owen WF Jr. African-Americans on maintenance dialysis: a review of racial differences in incidence, treatment, and survival. Adv Ren Replace Ther. 1997;4:3-12.
27. Bleyer AJ, Tell GS, Evans GW, et al. Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences. Am J Kidney Dis. 1996; 28:72-81.
28. Kausz AT, Obrador GT, Arora P, et al. Late initiation of dialysis among women and ethnic minorities in the United States. J Am Soc Nephrol. 2000;11:2351-2357.
29. Salahudeen AK, Deogaygay B, Fleischmann E, et al. Race-dependent survival disparity on hemodialysis: higher serum aluminum as an independent risk factor for higher mortality in whites. Am J Kidney Dis. 2000;36:1147-1154.
30. Pei YP, Greenwood CM, Chery AL, et al. Racial differences in survival of patients on dialysis. Kidney Int 2000;58:1293-1299.
31. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
32. Border WA, Noble NA. Interactions of transforming growth factor beta and angiotensin II in renal fibrosis. Hypertension 1998;31:181-188.
33. Safian RD, Textor SC. Renal artery stenosis. N Engl J Med. 2001;344:431-442.
34. Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing cardiac catheterization. Kidney Int. 2001;60:1490-1497.
35. Conlon PJ, O'Riordan E, Karla PA. New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular disease. Am J Kidney Dis. 2000;35:573-587.
36. Conlon FJ, Athirakul K, Kovalik E, et al. Survival in renal vascular disease. J Am Soc Nephrol. 1998;9:252-256.
37. Setaro JF, Saddler MC, Chen CC, et al. Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Hypertension. 1991;18:289-298.
38. Mann SJ. Captopril renal scan for detecting renal artery stenosis. Arch Intern Med. 2003;163:630-631.
39. Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36:443-451.
40. Bongers V, Bakker J, Beutler JJ, et al. Assessment of renal artery stenosis: comparison of captopril renography and gadolinium-enhanced breath-hold MR angiography. Clin Radiol. 2000;55:346-353.
41. Riehl J, Schmidt H, Bongartz D, et al. Renal artery stenosis: evaluation with color duplex ultrasonography. Nephrol Dial Transplant. 1997;12:1608-1614.
42. Hua HT, Hood DB, Jensen CC, et al. The use of colorflow duplex scanning to detect significant renal artery stenosis. Ann Vasc Surg. 2000;14:118-124.
43. Leung DA, Hagspeil KD, Angle JF, et al. MR angiography of the renal arteries. Radiol Clin North Am. 2002;40:847-865.
44. Volk M, Strotzer M, Lenhart M, et al. Time-resolved contrast-enhanced MR angiography of renal artery stenosis: diagnostic accuracy and interobserver variability. AJR Am J Roentgenol. 2000;174:1583-1588.
45. Taylor DC, Kettler MD, Moneta GL, et al. Duplex ultrasound scanning in the diagnosis of renal artery stenosis: a prospective evaluation. J Vasc Surg. 1988;7:363-369.
46. Strandness DE Jr. Duplex imaging for the detection of renal artery stenosis. Am J Kidney Dis. 1994;24:674-678.
47. Olin JW, Piedmonte MR, Young JR, et al. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med. 1995; 122:833-838.
48. Prince MR, Schoenberg SO, Ward JS, et al. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features. Radiology. 1997;205:128-136.
49. Colyer WR Jr, Cooper CJ, Burket MW, Thomas WJ. Utility of a 0.014″ pressure-sensing guidewire to assess renal artery translesional systolic pressure gradients. Catheter Cardiovasc Interv. 2003;59:372-377.
50. Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344:410-417.
51. Hansen KJ, Tribble RW, Reavis SW, et al. Renal duplex sonography: evaluation of clinical utility. J Vasc Surg. 1990;12:227-236.
52. Rubin GD, Dake MD, Napel S, et al. Spiral CT of renal artery stenosis: comparison of three-dimensional rendering techniques. Radiology. 1994;190:181-189.
53. Rubin GD, Alfrey EJ, Dake MD, et al. Assessment of living renal donors with spiral CT. Radiology. 1995;195:457-462.
54. Pozniak MA, Balison DJ, Lee FT Jr, et al. CT angiography of potential renal transplant donors. Radiographics. 1998;18:565-587.
55. Urban BA, Ratner LE, Fishman EK. Three-dimensional volume-rendered CT angiography of the renal arteries and veins: normal anatomy, variants, and clinical applications. Radiographics. 2001;21:373-386.
56. Beregi JP, Elkohen M, Deklunder G, et al. Helical CT angiography compared with arteriography in the detection of renal artery stenosis. AJR Am J Roentgenol. 1996;167:495-501.
57. Johnson PT, Halpern EJ, Kuszyk BS, et al. Renal artery stenosis: CT angiography - comparison of real-time volume-rendering and maximum intensity projection algorithms. Radiology. 1999;211:337-343.
58. Willmann JK, Wildermuth S, Pfammatter T, et al. Aortoiliac and renal arteries: prospective intraindividual comparison of contrast-enhanced three-dimensional MR angiography and multi-detector row CT angiography. Radiology. 2003;226:798-811.
59. Snidow JJ, Johnson MS, Harris VJ, et al. Three-dimensional gadolinium-enhanced MR angiography for aortoiliac inflow assessment plus renal artery screening in a single breath hold. Radiology. 1996;198:725-732.
60. Steffens JC, Link J, Grassner J, et al. Contrast-enhanced, K-space-centered, breath-hold MR angiography of the renal arteries and the abdominal aorta. J Magn Reson Imaging. 1997; 7:617-622.
61. Hany TF, Debatin JF, Leung DA, et al. Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology. 1997;204:357-362.
62. De Cobelli F, Vanzulli A, Sironi S, et al. Renal artery stenosis: evaluation with breath-hold, three-dimensional, dynamic, gadolinium-enhanced versus three-dimensional, phase-contrast MR angiography. Radiology. 1997; 205:689-695.
63. Rieumont MJ, Kaufman JA, Geller SC, et al. Evaluation of renal artery stenosis with dynamic gadolinium-enhanced MR angiography. AJR Am J Roentgenol. 1997;169:39-44.
64. Bakker J, Beek FJ, Beutler JJ, et al. Renal artery stenosis and accessory renal arteries: accuracy of detection and visualization with gadolinium-enhanced breath-hold MR angiography. Radiology. 1998;207:497-504.
65. Schoenberg SO, Bock M, Knopp MV, et al. Renal arteries: optimization of three-dimensional gadolinium-enhanced MR angiography with bolus-timing-independent fast multiphase acquisition in a single breath hold. Radiology. 1999;211:667-679.
66. Hahn U, Miller S, Nagele T, et al. Renal MR angiography at 1.0 T: three-dimensional (3D) phase-contrast techniques versus gadolinium-enhanced 3D fast low-angle shot breath-hold imaging. AJR Am J Roentgenol. 1999; 172:1501-1508.
67. Fain SB, King BF, Breen JF, et al. High-spatial-resolution contrast-enhanced MR angiography of the renal arteries: a prospective comparison with digital subtraction angiography. Radiology. 2001;218:481-490.
68. Tan KT, van Beek EJ, Brown PW, et al. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol. 2002;57:617-624.
69. Nahman NS Jr, Maniam P, Hernandez RA Jr, et al. Renal artery pressure gradients in patients with angiographic evidence of atherosclerotic renal artery stenosis. Am J Kidney Dis. 1994; 24:695-699.
70. Wasser MN, Westenberg J, van der Hulst VP, et al. Hemodynamic significance of renal artery stenosis: digital subtraction angiography versus systolically gated three-dimensional phase-contrast MR angiography. Radiology. 1997;202:333-338.
71. Sos TA, Saddekini S, Pickering TG, Laragh JH. Technical aspects of percutaneous transluminal angioplasty in renovascular disease. Nephron. 1986;44-S:45-50.
72. Gross CM, Kramer J, Weingartner O, et al. Determination of renal arterial stenosis severity: comparison of pressure gradient and vessel diameter. Radiology. 2001;220:751-756.
73. Bax L, Mali WP, Buskus E, et al. The benefit of stent placement and blood pressure and lipid lowering for the prevention of progression of renal dysfunction caused by atherosclerotic ostial stenosis of renal artery. The STAR study: rationale and study design. J Nephrol. 2003; 16:807-812.
74. Lewis EJ, Hunsicker LJ, Baim RP, Rhode D. The effects of angiotensin converting enzyme inhibition on diabetic nephropathy: The Collaborative Study Group. N Engl J Med. 1993;329:1456-1462.
75. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcome in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861-869.
76. The GISEN (Gruppo Italiiano di Studi Epidemiologici in Nefrologia) Group. Randomised, placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet. 1997;349:1857-1863.
77. Textor SC. Angiotensin converting enzyme inhibitors in renovascular hypertension. Cardiovasc Drugs Ther. 1990;4:229-235.
78. Caps MT, Perissinotto C, Zierler E, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998;98:2866-2872.
79. Dean RH. Renal artery stenosis surgery: aortorenal by-pass. J Mal Vasc 1994;9-S:92-95.
80. Lederman RJ, Mendelsohn FO, Santos R, et al. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J. 2001;142:314-323.
81. Blum U, Krumme B, Flugel P, et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med. 1997;336:459-465.
82. Henry M, Amor M, Henry I, et al. Stents in the treatment of renal artery stenosis: long-term follow-up. J Endovasc Surg. 1999;6:42-51.
83. Klinge J, Mali WP, Puijlaert CB, et al. Percutaneous transluminal renal angioplasty: initial and long-term results. Radiology 1989; 171:501-506.
84. Weibull H, Berqvist D, Bergentz SE, et al. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: prospective randomized study. J Vasc Surg. 1993;18:841-850.
85. Ramsay LE, Waller PC. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. BMJ. 1990;300:569-572.
86. Klow NE, Paulsen D, Vatne K, et al. Percutaneous transluminal renal artery angioplasty using the coaxial technique. Ten years of experience from 591 procedures in 419 patients. Acta Radiol. 1998;39:594-603.
87. Dorros G, Prince C, Mathiak L. Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Catheter Cardiovasc Diagn. 1993;9:191-198.
88. Rocha-Singh KJ, Ahuja RK, Sung CH, Rutherford J. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Catheter Cardiovasc Interv. 2002;57:135-141.
89. White CJ, Ramee SR, Collins TJ, et al. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol. 1997;30:1445-1450.
90. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens. 1998;12:329-335.
91. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000; 342:1007-1014.
92. Dorros G, Jaff M, Mathiak L, He T. Multicenter Registry Participants. Multicenter Palmaz-Schatz stent renal artery stenosis revasculariztion registry report: four-year follow-up of 1,058 patients. Catheter Cardiovasc Interv. 2002;55:182-188.
93. Harden PN, MacLeod MJ, Rodger RSC, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet. 1997; 349:1133-1136.
94. Burket MW, Cooper CJ, Kennedy DJ, et al. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J. 2000;139:64-71.
95. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642-647.
96. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. QJM. 1999:92:159-167.
97. Boisclair C, Therasse E, Oliva VL, et al. Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: midterm technical and clinical results. AJR Am Roentgenol. 1997;168:245-251.
98. Zeller T, Muller C, Frank U, et al. Survival after stenting of severe atherosclerotic ostial renal artery stenosis. J Endovasc Ther. 2003; 10:539-545.
99. Zeller T, Frank U, Muller C, et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108:2244-2249.
100. Steinbach F, Novick AC, Campbell S, et al. Long-term survival after surgical revascularization for atherosclerotic renal artery disease. J Urol. 1997;158:38-41.
101. Schreiber MJ, Pohl MA. Preserving renal function by revascularization. Annu Rev Med. 1990;41:423-429.
102. Novick AC. Long-term results of surgical revascularization for renal artery disease. Urol Clin North Am. 2001;28:827-831.
103. Cambria RP, Brewster DC, L'Italien G, et al. Simultaneous aortic and renal artery reconstruction: evolution of an eighteen-year experience. J Vasc Surg. 1995;21:916-924.
104. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomized trial. Lancet. 1999;353:282-286.
105. Henry M, Klonaris C, Henry I, et al. Protected renal stenting with the PercuSurge Guardwire™ device: a pilot study. J Endovasc Ther. 2001;8:227-237.
106. Scoble JE. Do protection devices have a role in renal angioplasty and stent placement? Nephrol Dial Transplant. 2003;18:1700-1703.
107. Henry M, Henry I, Klonaris C, et al. Renal angioplasty and stenting under protection: the way for the future? Catheter Cardiovasc Interv. 2003;60:299-312.
108. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg. 2003;38:962-968.
109. Chrysant GS, Goldstein JA, Casserly IP, et al. Endovascular brachytherapy for treatment of bilateral renal artery in-stent restenosis. Catheter Cardiovasc Interv. 2003;59:251-254.
110. Aslam MS, Balasubramanian J, Greenspalm BR. Brachytherapy for renal artery in-stent restenosis. Catheter Cardiovasc Interv. 2003; 58:151-154.
111. Bax L, Mali WP, Van de Ven PJ, et al. Repeated intervention for in-stent restenosis of the renal arteries. J Vasc Interv Rad. 2002;13:1219-1242.
112. Radermacher J, Ellis S, Haller H. Renal insufficiency and progression of renal disease. Hypertension. 2002;39:699-703.
113. Zierler RE, Bergelin RO, Davidson RC, et al. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens. 1996;9:1055-1061.
114. Caps MT, Zierler RE, Polissar NL, et al. Risk of atrophy in kidney with atherosclerotic renal artery stenosis. Kidney Int. 1998;53:735-742.
115. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984; 11:383-392.
116. Mailloux LU, Napolitano B, Bellucci AG, et al. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis. 1994;24:622-629.
117. Eggers PW, Connerton R, McMullan M. The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival. Health Care Financ Rev. 1984;5:69-88.
118. Kennedy DJ, Colyer WR, Brewster PS, et al. Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis. 2003;42:926-935.
119. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization treatment for atherosclerotic renal artery stenosis. Circulation. 1998; 98:642-647.
120. Johansson M, Herlitz H, Jensen G, et al. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens. 1999;7:1743-1750.
121. Naidu SS, Sezler F, Jacobs A, et al. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol. 2003;92:1160-1164.
122. Xue F, Bettmann MA, Langdon DR, Wivell WA. Outcome and cost comparison of percutaneous transluminal renal angioplasty, renal artery stent placement, and renal arterial bypass grafting. Radiology. 1999;212:378-384.
123. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001; 345:479-486.
124. Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106:100-105.
125. Khosla S, White CJ, Collins TJ, et al. Effects of renal artery stent implantation in patients with renovascular hypertension presenting with unstable angina or congestive heart failure. Am J Cardiol. 1997;80:363-366.
126. Yang J, Hu D, Liu K, et al. High incidence of renal artery stenosis in patients undergoing coronary angiography. Zhonghua Nei Ke Za Zhi. 2002;41:24-27.
127. Song HY, Hwang JH, Noh H, et al. The prevalence and associated risk factors of renal artery stenosis in patients undergoing cardiac catheterization. Yonsei Med J. 2000;41:219-225.
128. Martin LG, Rundback JH, Sacks D, et al. Quality improvement guidelines for angiography, angioplasty. and stent placement in the diagnosis and treatment of renal artery stenosis in adults. J Vasc Interv Radiol. 2002;13:1069-1083.